InVivo Therapeutics Holdings Corp. Gains 136.94%
Tue, Feb 06, 2024 at 07:16 PM
InVivo Therapeutics Holdings Corp. (NVIV:NASDAQ) jumped higher at $0.53, a gain of 136.9%. On Tue, Feb 06, 2024, NVIV:NASDAQ touched a New 2-Week Intraday High of $1.05. From Tue, Jan 23, 2024, the stock recorded 30.00% Up Days and 45.45% Green Days
The stock spiked on Tue, Feb 06, 2024 at $1.05 with a volume of 186M+.
About InVivo Therapeutics Holdings Corp. (NVIV:NASDAQ)
InVivo Therapeutics Holdings Corp is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries.
Top 10 Gainers:
- InVivo Therapeutics Holdings Corp. (NVIV:NASDAQ), 136.94%
- USD Partners LP (USDP:NYSE), 93.39%
- MedAvail Holdings Inc. (MDVL:NASDAQ), 92.4%
- ADDvantage Technologies Group, Inc. (AEY:NASDAQ), 77.14%
- Equillium, Inc. (EQ:NASDAQ), 52.78%
- Zenvia Inc. (ZENV:NASDAQ), 52.14%
- Meiwu Technology Company Limited (WNW:NASDAQ), 45%
- Immunome Inc. (IMNM:NASDAQ), 36.91%
- Tellurian Inc. (TELL:NYSEMKT), 32.57%
- Tenax Therapeutics, Inc. (TENX:NASDAQ), 31.01%